Fentanyl Citrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Fentanyl Citrate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 20, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6026-05
- Dosage Form
- Injection
- Presentation
- Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)
- Initial Posting
- Dec 20, 2023
Reason
Other